Skip to main content
SpringerLink
Log in

Oral Contraceptive Steroids and Arteriosclerosis

  • Chapter
New Aspects of Metabolism and Behaviour of Mesenchymal Cells during the Pathogenesis of Arteriosclerosis

Part of the book series: Abhandlungen der Rheinisch-Westfälischen Akademie der Wissenschaften ((ARAW,volume 87))

  • 53 Accesses

Abstract

The pattern of plasma lipoprotein levels is to a high degree dependent on endogenous and exogenous sex steroids. As high LDL-cholesterol (CH) and low HDL-CH concentrations are assumed to be involved in the development of arteriosclerosis, attention has to be paid to changes in lipid metabolism on account of alterations in the hormonal status as well as treatment with estrogens, progestogens or androgens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hemer, H.A., Valles de Bourges, V., Ayala, J.J., Brito, G., Diaz-Sanchez, V., Garza-Flores, J.: Variations in serum lipids and lipoproteins throughout the menstrual cycle. Fertil Steril. 1985; 44: 80–84.

    Google Scholar 

  2. Tikkanen, M.J., Kuusi, T., Nikkilä, E.A., Stenman, U.H.: Variation of postheparin plasma hepatic lipase by menstrual cycle. Metabolism. 1986; 35: 99–104.

    Article  PubMed  CAS  Google Scholar 

  3. Desoye, G., Schweditsch, M.O., Pfeiffer, K.P., Zechner, R., Kostner, G.M.: Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J. Clin. Endocrinol Metab. 1987; 64: 704–712.

    Article  PubMed  CAS  Google Scholar 

  4. Campos, H., McNamara, J.R., Wilson, P.W.F., Ordovas, J.M., Schaefer, E.J.: Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 1988; 67: 30–35.

    Article  PubMed  CAS  Google Scholar 

  5. Witteman, J.C.M., Grobbee, D.E., Kok, F.J., Hofman, A., Valkenburg, H.A.: Increased risk of atherosclerosis in women after the menopause. Br. Med. J. 1989; 298: 642–644.

    Article  CAS  Google Scholar 

  6. Parrish, H.M., Carr, C.A., Hall, D.G., King, T.M.: Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am. J. Obstet. Gynecol. 1967; 99: 155–162.

    PubMed  CAS  Google Scholar 

  7. Szajderman, M., Oliver, M.F.: Spontaneous premature menopause, ischaemic heart disease and serum lipids. Lancet. 1963; I: 962–965.

    Article  Google Scholar 

  8. Gordon, T., Kannel, W.B., Hjortland, M.C., McNamara, P.: Menopause and coronary heart disease. The Framingham Study. Ann. Int. Med. 1978; 89: 157–161.

    PubMed  CAS  Google Scholar 

  9. Kuhl, H.: Atherosklerose-Prophylaxe durch Östrogensubstitution? Geburtsh. Frauenheilk. 1988; 48: 747–756.

    Article  CAS  Google Scholar 

  10. Fahraeus, L.: The effects of estradiol on blood lipids and lipoproteins in postmenopausal women. Obstet. Gynecol. 1988; 72: 18S - 22S.

    PubMed  CAS  Google Scholar 

  11. Knopp, R.H.: The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet. Gynecol. 1988; 72: 23S - 30S.

    PubMed  CAS  Google Scholar 

  12. Larsson-Cohn, U., Fahraeus, L., Wallentin, L., Zador, G.: Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril. 1981; 35: 172–179.

    PubMed  CAS  Google Scholar 

  13. Fotherby, K.: Oral contraceptives, lipids and cardiovascular disease. Contraception. 1985; 31: 367–394.

    Article  PubMed  CAS  Google Scholar 

  14. Lipson, A., Stoy, D.B., LaRosa, J.C. et al.: Progestins and oral contraceptive-induced lipoprotein changes: a prospective study. Contraception. 1986; 34: 121–134.

    Article  PubMed  CAS  Google Scholar 

  15. Burkman, R.T.: Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy. Fertil Steril. 1988; 49: 39S - 50S.

    PubMed  CAS  Google Scholar 

  16. Knopp, R.H.: Cardiovascular effects of endogenous and exogenous sex hormones over a woman’s lifetime. Am. J. Obstet. Gynecol. 1988; 158: 1630–1643.

    PubMed  CAS  Google Scholar 

  17. März, W., Jung-Hoffmann, C., Heidt, F., Gross, W., Kuhl, H.: Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 µg ethnylestradiol and 75 µg gestodene or 150 µg desogestrel. Contraception. 1990; 41: 245–258.

    Article  PubMed  Google Scholar 

  18. Kuhl, H., März, W., Jung-Hoffmann, C., Heidt, F., Gross, W.: Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives. Am. J. Obstet. Gynecol. 1990; 163 (Suppl.): 363–369.

    PubMed  CAS  Google Scholar 

  19. Fahraeus, L., Sydsj©, A., Wallentin, L.: Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate. Fertil Steril, 1986; 45: 503–506.

    CAS  Google Scholar 

  20. Schaefer, E.J., Foster, D.M., Zech, L.A., Lindgren, F.T., Brewer, H.B., Levy, R.I.: The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J. Clin. Endocrinol. Metab. 1983; 57: 262–267.

    Article  PubMed  CAS  Google Scholar 

  21. Tam, S.P., Archer, T.K., Deeley, R.G.: Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2. J. Biol. Chem. 1985; 260: 1670–1675.

    PubMed  CAS  Google Scholar 

  22. Knopp., R.H., Walden, C.E., Wahl, P.W., Hoover, J.J.: Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency. Am. J. Obstet. Gynecol. 1982; 142: 725–731.

    Google Scholar 

  23. Voorhof, L., Rosseneu, M., Caster, H., De Keersgieter, W.: Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins. J. Endocrinol. 1986; 111: 191–196.

    Article  Google Scholar 

  24. Glueck, C.J., Fallat, R.W., Scheel, D.: Effects of estrogenic compounds on triglyceride kinetics. Metabolism. 1975; 24: 537–545.

    Article  PubMed  CAS  Google Scholar 

  25. Shirai, K., Barnhart, R.L., Jackson, R.L.: Hydrolysis of human plasma high density lipoprotein2-phospholipids and triglycerides by hepatic lipase. Biochem. Biophys. Res. Commun. 1981; 100: 591–599.

    Article  PubMed  CAS  Google Scholar 

  26. Tikkanen, M.J., Kuusi, T., Nikkilä, EA., Sane, T.: Very low density lipoprotein tri-glyceride kinetics during hepatic lipase suppression by estrogen. FEBS Letters. 1985; 181: 160–164.

    Article  PubMed  CAS  Google Scholar 

  27. Tikkanen, M.J., Nikkilä, E.A.: Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am. Heart. J. 1987; 113: 562–567.

    Article  PubMed  CAS  Google Scholar 

  28. Silfverstolpe, G., Johnson, P., Samsioe, G., Svanborg, A., Gustafson, A.: Effects induced by two different estrogens on serum individual phospholipids and serum lecithin fatty acid composition. Horm. Metab. Res. 1981; 13: 141–145.

    CAS  Google Scholar 

  29. Bagdade, J.D., Subbaiah, P.V.: Influence of low estrogen-containing oral contraceptives on lipoprotein phospholipid composition and mononuclear cell membrane fluidity. J. Clin. Endocrinol. Metab. 1988; 66: 857–861.

    Article  PubMed  CAS  Google Scholar 

  30. Brown, M.S., Goldstein, J.L.: Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J. Clin. Invest. 1983; 72: 743–747.

    Article  PubMed  CAS  Google Scholar 

  31. Ben, F., Eckel, R.H., Kern, F.: Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J. Lipid. Res. 1986; 27: 645–651.

    Google Scholar 

  32. Cooper, A.D., Nutik, R., Chen, J.: Characterization of the estrogen induced lipoprotein receptor of rat liver. J. Lipid. Res. 1987; 28: 59–68.

    PubMed  CAS  Google Scholar 

  33. Kovanen, P.T., Brown, M.S., Goldstein, J.L.: Increased binding of low density lipoprotein to liver membranes from rats treated with 17nethinyl estradiol. J. Biol. Chem. 1979; 254: 11367–11372.

    PubMed  CAS  Google Scholar 

  34. Floren, C.H., Kushwaha, R.S., Hazzard, W.R., Albers, J.J.: Estrogen-induced increase in uptake of cholesterol-rich very low density lipoproteins in perfused rabbit liver. Metabolism. 1981; 30: 367–375.

    Article  PubMed  CAS  Google Scholar 

  35. Windier, E.E.T., Kovanen, P.T., Chao, Y.S., Brown, M.S., Havel, R.J., Goldstein, J.L.: The estradiol-stimulated lipoprotein receptor of rat liver. J. Biol. Chem. 1980; 255: 10464–10471.

    Google Scholar 

  36. Kushwaha, R.S., Hazzard, W.R., Gagne, C., Chait, A., Albers, J.J.: Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen. Ann. Int. Med. 1977; 87: 517–525.

    PubMed  CAS  Google Scholar 

  37. Stuyt, P.M.J., Demacker, P.N.M., van ‘t Laar, A.: A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia. Horm. metabol. Res. 1986; 18: 607–610.

    CAS  Google Scholar 

  38. Knopp, R.H., Heiss, G., Wahl, P.W.: Prevalence and clinical correlates of beta-migrating very-low-density lipoprotein. Am. J. Med. 1986; 81: 493–502.

    Article  PubMed  CAS  Google Scholar 

  39. Chait, A., Brunzell, J.D., Albers, Ji., Hazzard, W.R.: Type-III hyperlipoproteinemia (“remnant removal disease”). Lancet. 1977; I: 1176–1178.

    Google Scholar 

  40. Tikkanen, M.J., Nikkilä, E.A., Vartiainen, E.: Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet. 1978; II. 490–491.

    Article  Google Scholar 

  41. Davidoff, F., Tishler, S., Rosoff, C.: Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. New. Engl. J. Med. 1973; 289: 552–555.

    Article  PubMed  CAS  Google Scholar 

  42. Glueck, C.J., Scheel, D., Fishback, J., Steiner, P.: Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism. 1972; 21: 657–666.

    Article  PubMed  CAS  Google Scholar 

  43. Krauss, R.M.: Effects of progestational agents on serum lipids and lipoproteins. J. Reprod. Med. 1982; 8 (Suppl.): 503–510.

    Google Scholar 

  44. Kuusi, T., Nikkilä, E.A., Tikkanen, Mi., Sipinen, S.: Effects of two progrestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2. Atherosclerosis. 1985; 54: 251–262.

    CAS  Google Scholar 

  45. Tikkanen, Mi., Nikkilä, E.A., Kuusi, T., Sipinen, S.: Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity. Atherosclerosis. 1981; 40: 365–369.

    Article  Google Scholar 

  46. Crona, N., Silfverstolpe, G., Samsioe, G.: Changes in serum apo-lipoprotein AI and sexhormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinylestradiol. Contraception. 1984; 29: 26 1270.

    Google Scholar 

  47. Tikkanen, M.J., Kuusi, T., Nikkilä, E.A., Sipinen, S.: Post-heparin plasma hepatic lipase activity as predictor of high-density lipoprotein response to progestogen therapy: studies with cyproterone acetate. Maturitas. 1987; 9: 81–86.

    Article  PubMed  CAS  Google Scholar 

  48. März, W., Gross, W., Gahn, G., Romberg, G., Taubert, H.D., Kuhl, H.: A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins. Am. J. Obstet. Gynecol. 1985; 153: 287–293.

    PubMed  Google Scholar 

  49. Gustafson, A., Svanborg, A.: Gonadal steroid effects on plasma lipoproteins and individual phospholipids. J. Clin. Endocrinol Metab. 1972; 35: 203–207.

    Article  PubMed  CAS  Google Scholar 

  50. Glueck, C.J., Fallat, R.: Gonadal hormones and triglycerides. Proc. Roy. Soc. Med. 1974; 67: 667–669.

    PubMed  CAS  Google Scholar 

  51. µg desogestrel on lipid and lipoprotein metabolism in healthy volunteers, also in comparison with 30 µg EE + 150 µg levonorgestrel. Acta. Obstet. Gynecol. Scand. Suppl. 1982; 111: 55–60.

    Google Scholar 

  52. Kloosterboer, H.J., van Wayjen, R.G.A., van den Ende, A.: Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism. Contraception. 1986; 34: 135–144.

    Article  PubMed  CAS  Google Scholar 

  53. Gaspard, U.J., Buret, J., Gillain, D., Romus, M.A., Lambotte, R.: Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Contraception. 1985; 31: 395–408.

    Article  PubMed  CAS  Google Scholar 

  54. Harvengt, C., Desager, J.P., Gaspard, U., Lepot, M.: Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins. Contraception. 1988; 37: 565–575.

    Article  PubMed  CAS  Google Scholar 

  55. Bergink, E.W., Kloosterboer, H.J., Lund, L., Nummi, S.: Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins. Contraception. 1984; 30: 61–72.

    Article  PubMed  CAS  Google Scholar 

  56. Bertolini, S., Elicio, N., Cordera, R., Gapitanio, G.L., Montagna, G., Crose, S., Saturnino, M., Balestreri, R., De Cecco, L.: Effects of three low-dose oral contraceptive formulations on lipid metabolism. Acta. Obstet. Gynecol. Scand. 1987; 66: 327–332.

    Article  PubMed  CAS  Google Scholar 

  57. Van der Vange, N., Kloosterboer, H.J., Haspels, A.A.: Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions. Brit. J. Obstet. Gynaecol. 1987; 94: 559–567.

    Article  Google Scholar 

  58. Ahren, T., Lithell, H., Victor, A., Vessby, B., Johansson, E.D.B.: Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins. Contraception. 1981; 24: 451–468.

    Article  PubMed  CAS  Google Scholar 

  59. La Rosa, J.C.: The varying effects of progestins on lipid levels and cardiovascular disease. Am. J. Obstet. Gynecol. 1988; 158: 1621–1629.

    PubMed  Google Scholar 

  60. Mann, J.I., Inman, W.H.W., Thorogood, M.: Oral contraceptive use in older women and fatal myocardial infarction. Brit. Med. J. 1976; II: 445–447.

    Article  Google Scholar 

  61. Shapiro, S., Rosenberg, L., Slone, D., Kaufman, D.W., Stolley, P.D., Miettinen, O.S.: Oral-contraceptive use in relation to myocardial infarction. Lancet. 1979; I: 743–746.

    Article  Google Scholar 

  62. Realml, J.P., Goldzieher, J.W.: Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am. J. Obstet. Gynecol. 1985; 152: 729–798.

    Google Scholar 

  63. Engel, H.J., Engel, E., Behnke, K., Lichtlen, P.: Angiographische Befunde nach Herzinfarkt junger Frauen: Die Rolle oraler Kontrazeptiva. Herz. 1987; 12: 290–295.

    PubMed  CAS  Google Scholar 

  64. Adams, M.R., Clarkson, T.B., Koritnik, D.R., Nash, H.A.: Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fenil Steril. 1987; 47: 1010 1018.

    Google Scholar 

  65. Clarkson, T.B., Adams, M.R., Kaplan, J.R., Shively, CA., Koritnik, D.R.: From menarche to menopause: Coronary artery atherosclerosis and protection in cynomolgus monkeys. Am. J. Obstet. Gynecol. 1989; 160: 1280–1285.

    PubMed  CAS  Google Scholar 

  66. Glueck, C.J.: Nonpharmacologic and pharmacologic alteration of high-density cholesterol: Therapeutic approaches to prevention of atherosclerosis. Am. Heart. J. 1985; 110: 1107–1115.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Frauenklinik, Universität Frankfurt/Main, Germany

    Herbert Kuhl

Authors
  1. Herbert Kuhl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Westdeutscher Verlag GmbH Opladen

About this chapter

Cite this chapter

Kuhl, H. (1991). Oral Contraceptive Steroids and Arteriosclerosis. In: New Aspects of Metabolism and Behaviour of Mesenchymal Cells during the Pathogenesis of Arteriosclerosis. Abhandlungen der Rheinisch-Westfälischen Akademie der Wissenschaften, vol 87. VS Verlag für Sozialwissenschaften, Wiesbaden. https://doi.org/10.1007/978-3-322-99112-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-322-99112-6_14

  • Publisher Name: VS Verlag für Sozialwissenschaften, Wiesbaden

  • Print ISBN: 978-3-322-99114-0

  • Online ISBN: 978-3-322-99112-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation